Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
Teamwork toward a ‘Perfect Bullet’ for Leukemia

Teamwork toward a ‘Perfect Bullet’ for Leukemia

A trio of Wilmot investigators is developing a nanoparticle-based delivery system might be exactly the conduit that scientists have been looking for.

Pathologist Seeks Earlier Answers for Families with Lynch Syndrome

Pathologist Seeks Earlier Answers for Families with Lynch Syndrome

Lynch syndrome is one of the most common inherited conditions that raises a person’s risk of colorectal cancer. Pathologist Jennifer Findeis-Hosey, M.D., is looking for ways to identify clinical and pathological features of colon polyps that may indicate the condition before an individual at risk has developed cancer.

Cellular Environment Surrounding Cancer Cells: Friend or Foe?

Cellular Environment Surrounding Cancer Cells: Friend or Foe?

Studying the microenvironment is a research pillar at the Wilmot Cancer Institute, and scientists are looking at it from every angle. 

Cancer: How Do I Tell My Kids?

Cancer: How Do I Tell My Kids?

One of the hardest parts of a cancer diagnosis can be breaking the news to children. Wilmot Cancer Institute Social Worker Judy Zeeman-Golden shares advice on talking to kids about cancer.

New Clinical Trials Advance Treatment, Diagnosis of Gynecologic Cancers

New Clinical Trials Advance Treatment, Diagnosis of Gynecologic Cancers

Wilmot offers the most extensive portfolio of clinical trials for gynecologic cancers in the region. In addition to large national treatment trials, Wilmot also offers trials that are available only in Rochester, including one that is evaluating potential molecular biomarkers to predict the risk of a pelvic mass becoming cancerous.